Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Samuel Leopoldo Romero Guillena"'
Autor:
David Fraguas, David Almenta Gallego, Sergio Arques-Egea, Marcos Gómez-Revuelta, Carlos Gómez Sánchez-Lafuente, Daniel Hernández Huerta, Daniel Núñez Arias, Beatriz Oda Plasencia-García, Carlos Parro Torres, Samuel Leopoldo Romero-Guillena, Elena Ros Cucurul, Cecilio Alamo
Publikováno v:
International journal of psychiatry in clinical practice.
Aripiprazole is an antipsychotic with a partial agonism of dopamine DThrough one face-to-face session and online collaboration, we reached consensus and established practical recommendations based on scientific evidence and clinical experience. We cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f643fd11c6bd11b85de889222cc4617
https://pubmed.ncbi.nlm.nih.gov/35792729
https://pubmed.ncbi.nlm.nih.gov/35792729
Autor:
Samuel Leopoldo Romero Guillena, Beatriz Oda Plasencia García de Diego, José Antonio Cantalejo Conde
Publikováno v:
Libro Comunicaciones.
Objetivo: Evaluar la eficacia y tolerabilidad de la formulación trimestral de palmitato de paliperidona (PP 3m) en pacientes esquizofrénicos en comorbilidad con trastornos de uso de cannabis, que estaban en tratamiento previo durante al menos 24 me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1884dbe4fb8c2f1b6fd89de5c5225880
https://doi.org/10.17579/sepd2020p121
https://doi.org/10.17579/sepd2020p121
Autor:
Samuel Leopoldo Romero Guillena, Francisco Gotor Sanchez-Luengo, Beatriz Oda Plasencia García de Diego
Publikováno v:
Libro Comunicaciones.
Objetivo: Evaluar la eficacia y tolerabilidad del tratamiento con Vortioxetina en el trastorno depresivo mayor en comorbilidad con trastorno por consumo de sustancias. Metodología: 18 pacientes, de entre 21-55 años, diagnosticados de trastorno depr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd620ee4524c62cced37156fcbd98167
https://doi.org/10.17579/sepd2020p139
https://doi.org/10.17579/sepd2020p139
Publikováno v:
CNS Spectrums. 24:209-210
Study Objectives1. To assess the effectiveness, functionality and tolerability of Aripiprazole long-acting injectable (ALAI) in patients with stable schizophrenia2. Compare hospitalizations and emergency assists during 18-month period before (retrosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e66a4d323a0cb2a2418c36c4a6b9faf
https://doi.org/10.1017/s1092852919000506
https://doi.org/10.1017/s1092852919000506
Publikováno v:
CNS Spectrums. 24:211-212
Study ObjectivesTo assess differences in cognitive impairment in a group of patients with schizophrenia receiving first-generation long-acting antipsychotics (FG-LAI) versus Aripiprazole long-actinginjectable (ALAI).MethodA descriptive, cross-section
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3359960ae46935f606aed062ea881a8
https://doi.org/10.1017/s1092852919000531
https://doi.org/10.1017/s1092852919000531